Esperion Therapeutics (ESPR) EBIT Growth (3y) (2015 - 2026)

Esperion Therapeutics (ESPR) EBIT Growth (3y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 273.62%
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 3.84%
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -59.82%
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 4.63%
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -30.05%
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 54.58%
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 40.17%
10 Esperion Therapeutics 799.30 Mn 643.14 Mn 45.53 Mn 48.65%

Historic Data

Download Data
DateValue
Mar 31, 2026 48.65%
Dec 31, 2025 58.80%
Sep 30, 2025 37.92%
Jun 30, 2025 28.77%
Mar 31, 2025 19.90%
Dec 31, 2024 57.01%
Sep 30, 2024 34.00%
Jun 30, 2024 27.64%
Mar 31, 2024 42.15%
Dec 31, 2023 23.75%
Sep 30, 2023 30.08%
Jun 30, 2023 -31.75%
Mar 31, 2023 13.25%
Dec 31, 2022 10.33%
Sep 30, 2022 14.14%
Jun 30, 2022 1.79%
Mar 31, 2022 -35.62%
Dec 31, 2021 2.84%
Sep 30, 2021 -3.31%
Jun 30, 2021 11.21%